isosorbide-5-mononitrate has been researched along with Pulmonary Hypertension in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Cheng, Y; Gong, Y; Huang, Z; Kong, H; Li, H; Mou, Y; Qian, S; Wang, H; Xie, W; Zhang, Y | 1 |
Barberà, JA; Burgos, F; Melgosa, MT; Pizarro, S; Ricci, GL; Roca, J; Rodriguez-Roisin, R; Valera, JL | 1 |
Angrill, J; Barberà, JA; Bosch, J; García-Pagán, JC; Ribas, J; Roca, J; Rodriguez-Roisin, R | 1 |
Bhan, A; Higenbottam, TW; Rennie, IG | 1 |
4 other study(ies) available for isosorbide-5-mononitrate and Pulmonary Hypertension
Article | Year |
---|---|
Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats.
Topics: Animals; Cardiomegaly; Drug Design; Fibrosis; Hypertension, Pulmonary; Isosorbide Dinitrate; Nitric Oxide Donors; Oleanolic Acid; Rats; Vascular Remodeling; Vasodilation | 2018 |
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Epoprostenol; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Injections, Intravenous; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitric Oxide; Pulmonary Circulation; Respiratory Function Tests; Vascular Resistance; Vasodilator Agents | 2007 |
Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
Topics: Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isosorbide Dinitrate; Middle Aged; Vasodilator Agents | 1999 |
Central retinal vein occlusion associated with primary pulmonary hypertension.
Topics: Adult; Anticoagulants; Female; Fluorescein Angiography; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Retinal Vein Occlusion; Vasodilator Agents; Visual Acuity; Warfarin | 2001 |